Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)
ID: 355438Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Building Sustainable Software Tools for Open Science" under the R03 Clinical Trial Not Allowed program. This initiative aims to enhance the sustainability and impact of research software tools by promoting best practices in software development and fostering collaboration between researchers and software engineers, ultimately supporting the advancement of open science practices. The program is particularly important for developing robust and scalable software that ensures research is reproducible, interoperable, and easily disseminated, aligning with NIH's Strategic Plan for Data Science. A total funding commitment of up to $6 million is expected to support 20-24 awards, with each award having a maximum budget of $300,000 over two years. Applications are due by December 4, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announced the funding opportunity titled "Building Sustainable Software Tools for Open Science" under the R03 Clinical Trial Not Allowed program. This initiative aims to enhance the sustainability and impact of research software tools used in various health-related fields by promoting best practices in software development and fostering collaboration between researchers and software engineers. Eligible applicants include higher education institutions, nonprofits, and for-profit organizations, with a total funding commitment of up to $6 million expected to support 20-24 awards, each with a maximum budget of $300,000 over two years. The program seeks to develop robust and scalable software, with a focus on enhancing software skills and community engagement for open science practices, ensuring research software is reproducible, interoperable, and easily disseminated. Applications are due by December 4, 2024, and reviewers will evaluate proposals based on significance, innovation, approach, and investigator qualifications. This funding opportunity aligns with NIH's Strategic Plan for Data Science, aimed at modernizing data infrastructure for health-related research.
    Similar Opportunities
    NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Research Software Engineer (RSE) Award (R50), a federal grant opportunity aimed at providing salary support for exceptional Research Software Engineers who contribute to the development and dissemination of biomedical and health-related software. This funding initiative seeks to enhance research outputs and promote career sustainability for individuals in non-traditional investigator paths, offering up to three years of funding with a maximum budget of $300,000. The NIH plans to commit approximately $6 million for 18-20 awards, with applications evaluated based on scientific merit, the qualifications of the RSE, and the potential impact on research productivity. Interested applicants must submit their proposals by December 4, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) to support small-scale research projects that can be completed in a short timeframe with limited resources. This program is designed to fund various types of research, including pilot studies, secondary data analysis, and the development of research methodologies, while explicitly excluding clinical trials. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and tribal governments, with each application allowed to request up to $50,000 per year for a project duration not exceeding two years. Interested parties should submit their applications electronically via Grants.gov by January 7, 2025, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for any inquiries regarding the funding announcement.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Notice of Intent to Publish a Funding Opportunity Announcement for Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a funding opportunity announcement for the "Computational Approaches to Curation at Scale for Biomedical Research Assets" grant, which will not allow clinical trials. This initiative aims to enhance access to secure and comprehensive datasets and computational models that can drive significant advancements in biomedical research, focusing on innovative computational methods to improve data curation processes. The anticipated funding amount for this grant is up to $250,000, with the announcement expected in Fall 2024 and the first application deadline set for February 5, 2025. Interested applicants are encouraged to develop collaborative projects in advance of the official announcement.
    Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for "Investigator Initiated Research in Computational Genomics and Data Science" (R01 Clinical Trial Not Allowed) aimed at advancing research in computational genomics, data science, and bioinformatics with applications to human health and disease. This initiative encourages innovative research efforts that enhance analytical methodologies, develop software tools, and improve genomic data management, with a focus on creating scalable solutions for increasingly large datasets. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and for-profit entities, with no cost-sharing requirement and a maximum budget of $500,000 in direct costs for projects not exceeding five years. Interested applicants should submit their proposals by January 7, 2025, and can direct inquiries to grantsinfo@nih.gov for further assistance.
    NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03), which supports small clinical trials focused on basic experimental studies involving human participants. This funding opportunity aims to enhance understanding of fundamental phenomena without immediate application towards products or processes, aligning with the NICHD's mission in human development, behavior, and health. Grants are available for up to $50,000 in direct costs per year, with a maximum project duration of two years, and applications must be submitted by January 7, 2025. Interested applicants can find more information and application details at the NIH website or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled “Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed),” aimed at supporting exploratory research for innovative biomedical technologies. This initiative focuses on high-risk projects that have not yet established feasibility, specifically targeting the development of tools such as laboratory instruments, algorithms, and chemical reagents, while excluding applications that address specific biological questions or present existing proof of concept data. Eligible applicants can request funding of up to $275,000 over two years, with a maximum of $200,000 in any single year, and applications are due by May 7, 2025. For further details, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or refer to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-126.html.
    Early-stage Biomedical Data Repositories and Knowledgebases (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Early-stage Biomedical Data Repositories and Knowledgebases," aimed at supporting the development of new or significantly modified data repositories and knowledgebases that enhance biomedical research. This initiative encourages applications from a diverse range of eligible organizations, including higher education institutions and non-profits, with a funding cap of $350,000 per year for a maximum project duration of four years. The importance of this funding lies in its potential to align with FAIR data principles, thereby improving the ecosystem for biomedical research. Interested applicants should note that the application period opens on September 30, 2023, with a Notice of Award expected by early 2024; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R03 Small Grant Program to enhance clinical trial readiness for rare diseases, disorders, and syndromes. This initiative aims to support research that identifies critical needs for advancing therapeutics or diagnostics in rare diseases, which are defined as affecting fewer than 200,000 individuals in the U.S., by developing better biomarkers, clinical outcome measures, and insights into the natural history of these conditions. The program emphasizes the importance of partnerships among researchers, industry, and patient advocacy groups to optimize clinical trial designs, while explicitly stating that applications should not propose clinical trials directly but focus on pre-trial research activities. The maximum funding available for each project is $100,000 over a two-year period, with applications due by October 17, 2024. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-160.html.
    NICHD Small Research Grant Program (R03 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NICHD Small Research Grant Program (R03 Clinical Trial Required) to support clinical trials that align with the mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). This grant program is designed to fund small research projects with a maximum budget of $50,000 in direct costs per year, for a duration of up to two years, focusing on areas such as human development, childhood development, and rehabilitation medicine. Eligible applicants include a diverse range of organizations, including higher education institutions, nonprofits, for-profits, and tribal governments, with all applications required to propose clinical trials and adhere to NIH submission guidelines. Interested parties should note that the application deadline is January 7, 2025, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further inquiries. More information can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-21-221.html.